8-K

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported):  February 17, 2009

                       Total Nutraceutical Solutions, Inc.
              ------------------------------------------------
               (Name of Small Business Issuer in its Charter)

            Nevada                   000-52864             26-0561199
 ----------------------------       ------------       ------------------
 (State or other jurisdiction       (Commission          (IRS Employer
      of incorporation)             File Number)       Identification No.)

          2811 Reidville Road, Suite 23, Spartanburg, SC      29301
          ----------------------------------------------   -----------
            (Address of Principal Executive Offices)       (Zip Code)

                             (864) 316-2909
                       ---------------------------
                       (Issuer's telephone number)


          -------------------------------------------------------------
          (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[_]  Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)
[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)
[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))
[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))


                                     1



Item 7.01  Regulation FD Disclosure

On February 17, 2009, Total Nutraceutical Solutions, Inc. (the "Company") a
Nevada corporation, issued a press release that the Company has entered into
an agreement with Hokto Kinoko to acquire mushroom spent substrate.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K and is incorporated herein by reference in its entirety.

Item 9.01  Financial Statements and Exhibits

(c) Exhibits:

99.1  Press release issued on February 17, 2009 by Total Nutraceutical
      Solutions, Inc.*


* This exhibit is intended to be furnished and shall not be deemed "filed"
  for purposes of the Securities Exchange Act of 1934, as amended.


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                               Total Nutraceutical Solutions, Inc.
                               -----------------------------------
                                            Registrant

                                By: /s/ Frank Arnone
                                ------------------------------------
                                Name:   Frank Arnone
                                Title:  President/Director


Dated:  February 17, 2009
        -----------------


                                    2

EX-99.1

Exhibit 99.1

Press Release                    Source:  Total Nutraceutical Solutions, Inc.

Total Nutraceutical Solutions Inks Deal with Hokto Kinoko to Utilize
Mushroom Spent Substrate

Tuesday February 17, 6:00 am ET




Spent Substrate Will Be Developed as a Nutritional Animal Feed Additive

SPARTANBURG, S.C.--(BUSINESS WIRE)--Total Nutraceutical Solutions, Inc. (TNS)
(OTCBB: TNUS - News) announced today that the company has signed an agreement
with Hokto Kinoko Co. ("Hokto") to acquire mushroom spent substrate from the
Hokto facility in San Marcos, CA. The 250,000 square foot growing facility for
fresh specialty mushrooms has the potential at full capacity to produce 20-25
tons of spent substrate per day. TNS plans to develop and market this material
as an animal feed additive with nutritional value via collaborative research
with the Department of Food Science at Pennsylvania State University.

"This agreement propels TNS into the forefront of nutritional supplementation
in the human and veterinary markets," stated Marvin S. Hausman MD, CEO, TNS.
"Research collaborations between our own scientists and those of the Department
of Food Science, Pennsylvania State University, will allow us to identify key
bioactive substances within the spent substrate which has the potential to
supplement the diets of humans and animals. These bioactive nutrients and
enzymes may act as natural potent anti-oxidants and anti-inflammatory agents
to increase the nutritional value of animal food products. The nutrients may
also prevent various diseases that afflict animals in the food chain as well
as many humans."

Mushroom substrate waste is defined as the spent substrate (growing media) and
all mushroom residuals resulting from cleaning the growing bottles after the
harvest of mushroom fruit bodies at the growing facility. The Hokto state-of-
the-art facility, the largest of its kind in the United States, will produce
the following mushrooms: Brown Beech (Buna Shimeji), White Beech (Bunapi(TM)),
King Trumpet (Pleurotus eryngii), and Maitake.

About Hokto Kinoko Company:

Hokto Kinoko Company USA is a wholly owned subsidiary of Hokuto Corporation,
headquartered in Nagano, Japan. Hokuto Corporation, a first section Tokyo
Stock Exchange Company, is the largest mushroom producer in Japan.

About Total Nutraceutical Solutions, Inc.:

Total Nutraceutical Solutions, Inc. is an emerging nutraceutical company with
a focus on discovering, formulating and marketing products composed primarily
of organic natural mushroom compounds that contain bioactive nutrients for
potential health benefits. TNS develops production and analytic technologies
for food and nutritional supplements composed primarily of mushrooms and their
mycelial biomasses. Novel clinical models and biomarkers will be used to show
nutritional and clinical efficacy of our products. In addition to preventative
healthcare formulations and nutritional approaches to a wide variety of human
conditions and illnesses, TNS also develops and acquires breakthrough
nutritional tools and products in the fields of animal husbandry and
livestock feeds.

Any statements contained in this press release that relate to future plans,
events or performance are forward-looking statements that involve risks and
uncertainties including, but not limited to, the risks associated with the
transaction described in this press release, and other risks identified in the
filings by Total Nutraceutical Solutions (TNS), Inc. with the Securities and
Exchange Commission. Further information on risks faced by TNS are detailed in
the Form 10-K for the year ended July 31, 2008 and in its subsequent Quarterly
Reports on Form 10-Q. These filings are or will become available on a website
maintained by the Securities and Exchange Commission at http://www.sec.gov.
The information contained in this press release is accurate as of the date
indicated. Actual results, events or performance may differ materially. TNS
does not undertake any obligation to publicly release the result of any
revision to these forward-looking statements that may be made to reflect
events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events.

Contact:

Total Nutraceutical Solutions, Inc.
Roberta Matta, 509-427-5132